Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02390453
Other study ID # R01AG045157
Secondary ID 1R01AG045157-01A
Status Completed
Phase N/A
First received
Last updated
Start date January 2015
Est. completion date October 25, 2019

Study information

Verified date March 2023
Source Indiana University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a randomized controlled trial (RCT) of the effectiveness of cognitive and exercise training versus control condition on cognitive function in older adults with mild cognitive impairment (MCI).


Description:

Exercise and cognitive training hold promise for delaying progression of MCI. Exercise improves cognitive ability, brain function, and brain structure in older adults. Cognitive training has been shown to durably improve mental abilities and functional status in older adults. In addition, persons with MCI respond to some forms of cognitive training just as robustly as healthy older adults. This pilot study is a 4 group design with a home-based multi-modal physical exercise intervention, cognitive training, combined cognitive and physical training, and a social contact control enrolling older adults with MCI. This pilot study is designed to be consistent with current recommended approaches to establishing trial feasibility. If the aims are achieved, it will provide a conceptual and practical rationale to support a large, multi-site, randomized clinical trial to test the efficacy of combined physical and cognitive training in delaying time to a clinical diagnosis of dementia.


Recruitment information / eligibility

Status Completed
Enrollment 201
Est. completion date October 25, 2019
Est. primary completion date October 25, 2019
Accepts healthy volunteers No
Gender All
Age group 65 Years and older
Eligibility Inclusion Criteria: - subjective memory complaint - minimal impairment in daily function per Functional Activity Questionnaire (FAQ) - sedentary - English speaking - access to telephone Exclusion Criteria: - dementia or Alzheimer disease - stroke, past 12 months - myocardial infarction, past 12 months - angina - Parkinson disease - multiple sclerosis - epilepsy - AIDS - brain tumor, infection, or surgery - brain injury with > 30 minute LOC - schizophrenia - bipolar disorder - cancer with short life expectancy - current chemotherapy or radiation therapy - depression - alcohol consumption = 8 drinks per week for women, or =15 drinks per week for men - prescription of Aricept or Namenda, past or present - self-reported difficulty reading a newspaper (low visual acuity) - low hearing or communicative ability (examiner-rated) that would interfere with interventions and outcome assessments - prior involvement in similar cognitive training studies, programs, or online training - prior use of online brain training or brain fitness programs - unable to pass the Exercise Assessment and Screening for You (EASY) - living in nursing home - scheduling conflicts with intervention schedule - unwilling to use a computer or be on video conferencing - Baseline blood pressure of Systolic > 180 - Baseline blood pressure of Diastolic > 100 - Baseline pulse of < 40 or > 100 - unable to provide informed consent

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Combined Cognitive and Physical
Combined modules provide Cognitive training from Posit Science designed to improve information processing speed, learning, memory, and attention, and Physical training focused on seated aerobic and progressive resistance exercises designed to improve aerobic capacity, muscular strength, and endurance consistent with current exercise recommendations for older adults.
Cognitive
Cognitive modules from Posit Science are designed to improve information processing speed, learning, memory, and attention.
Physical
Physical modules are focused on seated aerobic and progressive resistance training designed to improve aerobic capacity, muscular strength, and endurance consistent with current exercise recommendations for older adults.
Active Control
Control modules provide social contact for group discussion of health and successful aging.

Locations

Country Name City State
United States Indiana University Indianapolis Indiana

Sponsors (2)

Lead Sponsor Collaborator
Indiana University National Institute on Aging (NIA)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Cognitive function composite score as measured by individually-administered tests of psychomotor speed, complex sequencing, and list learning. The cognitive composite is derived from: WAIS-IV Symbol Search, Trail Making Test Part B, and Rey Auditory Verbal Learning Test. End of treatment at 12-weeks.
Primary Average participant self-ratings of intervention acceptability. Average of individual Likert self-ratings of the interventions (where 1 = very unenjoyable, 2 = not enjoyable, 3 = neutral, 4 = enjoyable, and 5 = very enjoyable) for each session of the 12-week intervention. From date of randomization until the date of the final training session or the end of the 12-week intervention, whichever came first.
Primary Participant adherence to treatment. Number of training sessions attended divided by the the total number of sessions available. From date of randomization until the date of the final training session or the end of the 12-week intervention, whichever came first.
Primary Participant adherence to outcome assessment. Number of participants completing the post-training outcome assessment divided by the total number randomized. End of treatment at 12-weeks.
Primary Number of participants with study-related adverse events (AE) by treatment arm. From enrollment through end of treatment at 12-weeks.
See also
  Status Clinical Trial Phase
Completed NCT04513106 - Promoting Advance Care Planning for Persons With Early-stage Dementia in the Community: a Feasibility Trial N/A
Recruiting NCT06011681 - The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
Recruiting NCT04522739 - Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease Phase 4
Active, not recruiting NCT03167840 - Falls Prevention Through Physical And Cognitive Training in Mild Cognitive Impairment N/A
Active, not recruiting NCT03676881 - Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
Not yet recruiting NCT05041790 - A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate Compared to Placebo in Patients With Degenerative Mild Cognitive Impairment Phase 4
Recruiting NCT04121156 - High Definition Transcranial Direct Current Stimulation (HD-tDCS) in Patients With Mild Cognitive Impairment N/A
Recruiting NCT03605381 - MORbidity PRevalence Estimate In StrokE
Completed NCT02774083 - Cognitive Training Using Feuerstein Instrumental Enrichment N/A
Completed NCT01315639 - New Biomarker for Alzheimer's Disease Diagnostic N/A
Enrolling by invitation NCT06023446 - Can (Optical Coherence Tomography) Pictures of the Retina Detect Alzheimer's Disease at Its Earliest Stages?
Completed NCT04567745 - Automated Retinal Image Analysis System (EyeQuant) for Computation of Vascular Biomarkers Phase 1
Recruiting NCT05579236 - Cortical Disarray Measurement in Mild Cognitive Impairment and Alzheimer's Disease
Completed NCT03583879 - Using Gait Robotics to Improve Symptoms of Parkinson's Disease N/A
Terminated NCT02503501 - Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease Phase 2
Not yet recruiting NCT03740178 - Multiple Dose Trial of MK-4334 in Participants With Alzheimer's Clinical Syndrome (MK-4334-005) Phase 1
Active, not recruiting NCT05204940 - Longitudinal Observational Biomarker Study
Recruiting NCT02663531 - Retinal Neuro-vascular Coupling in Patients With Neurodegenerative Disease N/A
Recruiting NCT06150352 - Sleep Apnea, Neurocognitive Decline and Brain Imaging in Patients With Subjective or Mild Cognitive Impairment
Recruiting NCT03507192 - Effects of Muscle Relaxation on Cognitive Function in Patients With Mild Cognitive Impairment and Early Stage Dementia. N/A